Page 26 - ITPS-6-2

INNOSC Theranostics and
Pharmacological Sciences TDM of imipramine: Correlation and case study

Consent for publication Washington, D.C.: American Psychiatric Association
Publishing.
Not Applicable.
https://doi.org/10.1176/appi.books.9781615371624
Availability of data 12. Schwartz TL, Sachdeva S, Stahl SM, 2016, Genetic and

Not Applicable. pharmacokinetic factors that impact the therapeutic window
of imipramine. J Psychiatr Pract, 22: 392–399.
References https://doi.org/10.1097/PRA.0000000000000179

1. Yao LP, Li YF, Sun HF, 2019, Therapeutic drug monitoring 13. Davanzo F, Urso S, Fagiolini A, 2013, The pharmacokinetics
of imipramine in the treatment of depression. Int J Clin Exp and interactions of antidepressants. In: Handbook of Drug
Med, 12: 12931–12936. Interactions: A Clinical and Forensic Guide. New Jersey:
2. Smith HJ, Meredith SE, Appleton KM, 2019, Therapeutic Humana Press, p271–308.
drug monitoring of tricyclic antidepressants: How does 14. Bhatia SC, Bhatia SK, 2012, Drug Metabolism and
it inform clinical practice? Psychopharmacology (Berl), Pharmacokinetics. Netherlands: Elsevier.
236: 1037–1051.
15. Lebel D, Czornyj L, 1986, Imipramine and desipramine
3. Fong SY, Saff EB, Zisook S, 1985, Imipramine therapeutic pharmacokinetics in children: Lack of correlation with age.
monitoring in a case of refractory depression. J Clin Dev Pharmacol Ther, 9: 334–343.
Psychiatry, 46: 37–38.
https://doi.org/10.1159/000457519
4. Hicks JK, Swen JJ, Thorn CF, et al., 2013, Implementation
consortium. clinical pharmacogenetics implementation 16. Rasmussen BB, Brosen K, 1992, Pharmacokinetics of
consortium guideline for CYP2D6, CYP2C19, and CYP2C9 imipramine and desipramine in elderly patients. Ther Drug
genotypes and dosing of tricyclic antidepressants. Clin Monit, 14: 106–110.
Pharmacol Ther, 93: 402–408. https://doi.org/10.1097/00007691-199204000-00004
https://doi.org/10.1038/clpt.2013.2 17. Murthy BR, Srikumar G, 2008, Pharmacokinetic alterations
5. Crews KR, Gaedigk A, Dunnenberger HM, et al., 2014, in liver diseases. J Clin Exp Hepatol, 2: 242–248.
Clinical pharmacogenetics implementation consortium https://doi.org/10.1016/S0973-6883(08)60170-9s
guidelines for cytochrome P450 2D6 genotype and
codeine therapy: 2014 update. Clin Pharmacol Ther, 18. Hiemke C, Baumann P, Wittmann M, 1990, Imipramine and
95: 376–382. desipramine kinetics in patients with chronic renal failure.
J Clin Psychopharmacol, 10: 326–331.
https://doi.org/10.1038/clpt.2013.254
https://doi.org/10.1097/00004714-199010000-00005
6. Cipriani A, Barbui C, Butler R, et al., 2009, Depression in
Adults: Drug and Physical Treatments. Clinical Guideline 19. Mendell J, Zwisler J, 1979, Effects of heart failure and
[CG90]. London: National Institute for Health and Clinical cardiac output on imipramine disposition. J Clin Pharmacol,
Excellence. 19: 153–159.
https://doi.org/10.1002/j.1552-4604.1979.tb02520.x
7. Stahl SM, 2013, Stahl’s Essential Psychopharmacology:
Neuroscientific Basis and Practical Applications. 20. Hiemke C, Hartter S, 2000, Pharmacokinetics of selective
United Kingdom: Cambridge University Press. serotonin reuptake inhibitors. Pharmacol Ther, 85: 11–28.
8. Katzung BG, 2017, Basic and Clinical Pharmacology. United https://doi.org/10.1016/S0163-7258(99)00058-6
States: McGraw Hill.
21. Siniscalchi A, Gallelli L, Cassano T, 2016, Adverse drug
9. Preskorn SH, 2013, Clinical pharmacology of antidepressants. reactions to imipramine: A case series. J Pharmacol
In: Handbook of Clinical Neurology. Vol. 117. Netherlands: Pharmacother, 7: 199–202.
Elsevier, p291–305.
https://doi.org/10.4103/0976-500X.191180
10. Leucht S, Cipriani A, Spineli L, et al., 2013, Comparative 22. Baumann P, Hiemke C, 1995, Pharmacokinetics of
efficacy and tolerability of 15 antipsychotic drugs in antidepressants in the elderly. Ther Drug Monit, 17: 234–239.
schizophrenia: A multiple-treatments meta-analysis. Lancet,
382: 951–962. https://doi.org/10.1097/00007691-199506000-00008
https://doi.org/10.1016/S0140-6736(13)60733-3 23. Baumann P, 1988, Protein binding of psychotropic drugs
in vitro: A methodological problem. Psychopharmacology,
11. Schatzberg AF, Nemeroff CB, 2017, Tricyclic and tetracyclic
antidepressants. In: The American Psychiatric Association 94: 151–155.
Publishing Textbook of Psychopharmacology. Ch. 18. https://doi.org/10.1007/BF00735858

Volume 6 Issue 2 (2023) 6 https://doi.org/10.36922/itps.0505